Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

GOLD 2022 Webinars Webinar 8 Biomedical applications of gold in vivo applications and technologies, injectable nanoparticles and pharmacology Cancer nanomedicine Overcoming the challenges in current radiotherapy using gold nanoparticles Dr...

Hello friends, This email concerns a nominations for positions on the Board of Directors, and b proposals to host our 2023 annual meeting...

The CBS-ASC would like to invite you to our first CBS-ASC Biomaterials Panel Discussion against COVID-19 that will be held on Thursday, May 6, 2021, at 11 am MDT via zoom...

Dear Members and Friends of the Canadian Biomaterials Society, We have extended the Early Bird Registration period...

Liver cancer is the sixth most common cancer, and the second leading cause of cancer death1. The majority of liver cancer cases are hepatocellular carcinoma HCC ...

Protein-, lipid- and cell-based products constitute a significant portion of current and upcoming therapeutics and have become a prime focus of the pharmaceutical and biotechnology industries...

There is a necessity to improve the longevity of implants to avoid potential replacements for a growing number of implant recipients...

Two problems arise when replacing a patient artery by a synthetic vascular graft VG . The first one is the absence of endothelial lining on the lumen side of the graft, related to the inappropriate surface properties and textures, which leads to VG thrombosis...

First introduced over a century ago, total hip arthroplasty THA is a refined surgical intervention that allows for the recovery of function in a patient s debilitated hip joint for up to 10 to 15 years 1 , 2 ...